ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  

Found 34839 studies with search of:   United States

Hide studies that are not seeking new volunteers.
Show Display Options  Display Options

1 Completed The Effects of Illnesses on HIV Levels in the Body
Condition: HIV Infections
Intervention:
2 Completed A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
Condition: HIV Infections
Intervention: Drug: Zidovudine
3 Completed A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
Conditions: Herpes Simplex;   HIV Infections
Interventions: Drug: Valacyclovir hydrochloride;   Drug: Acyclovir
4 Completed A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition
Conditions: Anorexia;   Cachexia;   HIV Infections
Intervention: Drug: Megestrol acetate
5 Active, not recruiting Diagnostic Study of Patients With Stage I Testicular Cancer
Condition: Testicular Germ Cell Tumor
Interventions: Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: radionuclide imaging
6 Active, not recruiting Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
Conditions: Breast Cancer;   Cardiac Toxicity
Intervention: Procedure: management of therapy complications
7 Completed Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: docetaxel;   Drug: irinotecan hydrochloride
8 Completed Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Conditions: Anemia;   Breast Cancer;   Chronic Myeloproliferative Disorders;   Drug/Agent Toxicity by Tissue/Organ;   Leukemia;   Lung Cancer;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition;   Quality of Life;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: epoetin alfa;   Procedure: quality-of-life assessment
9 Active, not recruiting Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: filgrastim;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: vincristine sulfate
10 Recruiting Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
Conditions: Hematologic Diseases;   Anemia, Sickle Cell
Intervention: Drug: Hydroxyurea
11 Completed A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines
Condition: Schizophrenia
Intervention: Behavioral: Test strategy for implementation guideline
12 Completed Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Lymphoma
Interventions: Drug: fludarabine phosphate;   Drug: rituximab
13 Completed TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Nelfinavir;   Drug: Rifabutin
14 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Natalizumab
15 Active, not recruiting Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: cyclophosphamide;   Drug: filgrastim;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: methotrexate;   Drug: tacrolimus;   Drug: therapeutic allogeneic lymphocytes;   Procedure: peripheral blood stem cell transplantation
16 Completed EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Intervention: Drug: epothilone b
17 Completed Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
Condition: Malignant Melanoma
Intervention: Drug: HSPPC-96 or Oncophage
18 Active, not recruiting Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Interventions: Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
19 Active, not recruiting Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Conditions: Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: ixabepilone
20 Completed Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
21 Completed A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
Condition: Breast Neoplasms
Intervention: Drug: SU011248
22 Active, not recruiting A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care
Condition: Carcinoma, Hepatocellular
Intervention: Drug: DENSPM (diethylnorspermine)
23 Active, not recruiting Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
Condition: Sarcoma
Intervention: Drug: imatinib mesylate
24 Recruiting Two Dose Levels of Capecitabine With Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Anthracycline-Based Chemotherapy
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: docetaxel
25 Active, not recruiting TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1
Condition: HIV Infections
Intervention: Drug: TNX-355
26 Active, not recruiting Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: pemetrexed disodium
27 Completed Modafinil for the Treatment of Cocaine Dependence - 1
Condition: Cocaine-Related Disorders
Intervention: Drug: Modafinil
28 Active, not recruiting ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
Conditions: Pancreatic Cancer;   Adenocarcinoma
Intervention: Drug: ARQ 501 in combination with gemcitabine
29 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
30 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
31 Recruiting Therapy for Pediatric Hodgkin Lymphoma
Condition: Hodgkins Lymphoma
Interventions: Drug: VAMP Chemotherapy (Favorable Risk);   Drug: Stanford V Chemotherapy (Unfavorable Risk);   Procedure: Radiation therapy
32 Recruiting Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients
Condition: Parkinson Disease
Interventions: Drug: pramipexole IR;   Drug: ropinirole
33 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis of the Knee
Intervention: Drug: GW406381
34 Enrolling by invitation A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (ucb 34714)
35 Completed A Placebo-Controlled Study of Safety and Effectiveness of Myozyme in Patients With Late-Onset Pompe Disease
Conditions: Pompe Disease (Late-Onset);   Glycogen Storage Disease Type II (GSD-II);   Acid Maltase Deficiency Disease;   Glycogenosis 2
Interventions: Drug: Myozyme (alglucosidase alfa);   Drug: Placebo
36 Completed Pharmacokinetic Evaluation of Testosterone Gel (1%)
Conditions: Primary or Secondary Hypogonadism;   Constitutional Delay in Growth and Puberty (CDGP)
Intervention: Drug: Testosterone Gel (1%)
37 Recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer
Conditions: Hepatic Metastases;   Colorectal Cancer
Interventions: Drug: Bevacizumab HAI plus systemic chemotherapy;   Drug: HAI plus systemic chemotherapy
38 Completed A Study of AT1001 in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: AT1001 (migalastat hydrochloride)
39 Active, not recruiting Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
40 Completed An Open-Label, Prospective, Randomized, Multi-Center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Conditions: Cadaveric Donor Renal Transplantation;   Acute Renal Allograft Rejection;   Induction Therapy
Intervention: Drug: Thymoglobulin [Anti-thymocyte Globulin (rabbit)]
41 Completed Tamoxifen-MRI Study
Condition: Breast Cancer
Intervention: Drug: Tamoxifen
42 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
43 Completed Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
Condition: Actinic Keratosis
Intervention: Procedure: Photodynamic therapy with methyl aminolevulinate cream
44 Completed A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Bevacizumab
45 Completed Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Conditions: Dysmenorrhea;   Dyspareunia;   Endometriosis;   Pelvic Pain
Intervention: Drug: ERB-041
46 Active, not recruiting Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
47 Recruiting Phase 1b Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Breast Cancer
Condition: Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: AMG 706;   Drug: Docetaxel;   Drug: Paclitaxel
48 Completed Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Drug: imexon;   Drug: DTIC
49 Active, not recruiting Continuation of Follow-up of DES-Exposed Cohorts
Condition: Diethylstilbestrol (DES) Exposure
Intervention:
50 Completed A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.
Condition: Impotence
Interventions: Drug: Placebo;   Drug: Viagra (sildenafil citrate)

Studies Shown (1-50) Next (51-100) Show next page of results

RSS Feed for studies found by your search that were received in the last 14 days  RSS Feed for studies found by your search that were received in the last 14 days  

Show download Options  Download Options




Links to all studies - primarily for crawlers